... Volk Area Centralis® is excellent for critica...ization and changes from macular degeneration, ret...proliferative diabetic retinopathy and other retin...nt of these conditions providing excellent magnifi...
... original 130° QuadrAspheric lens has grown in...preferred wide field fundus laser lens. Its sleek ...age over competitive wide field lenses for periphe...ease of use. This lens is excellent for small pupi...
The Digital Wide Field Lens combines exceptional wide field views and high magnification. The enhanced double aspheric design and multi-layer coating provide high resolution stereo views of the retin
...ks Super VitreoFundus® provides ultra wide-fie... quick and comprehensive fundus exams at the slit ... a wide field of view through small pupils without...all pupil lenses. Delivering an incredible 124°...
Medicine Products:(Date:10/13/2008)...ir levels were lower than Alzheimer,s patients, he...althDay News) -- Parkinson,s disease patients are ...ients to have vitamin D deficiency, say researcher...Atlanta. , They compared vitamin D levels in 10...nd 99 healthy people matched for age and other fac...
(Date:10/13/2008)...., Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Fo... of the School for Children with,Hidden Intelligen...,training program., SCHI is a state-approved, pri...ndicapped, underprivileged children with special n... and alleviate the suffering of the,most vulnerabl...
(Date:10/13/2008)...perium(TM) Market Leading Content Rights Managemen...g the Loop on Their Content Spend, WEST CHESTER, ...ed,today that a leading global pharmaceutical manu...logy to become the primary platform for the,secure...d reporting,analytics for their new product video ...
(Date:10/13/2008)...s a significant problem in daily life, survey show.../ -- Approximately,three-quarters of people living...roblem in daily life, according to a National Psor... survey of 426 individuals with psoriasis and psor...nfluences their daily lives, shapes their,feelings...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Psoriasis Foundation Releases 2008 Study Results 2(Date:10/10/2008)...EEK, Mich., Oct. 10 /- Diplomat Speci...ce has selected Diplomat,Specialty Pharmacy to be ...scale, national Therapy Optimization Study for Mul...ear TOP MS study, is to examine the benefits of a,...ompliance, adherence and,patient outcomes. Targete...
(Date:10/10/2008)...ass., Oct. 10 /- Boston Sci...the schedule of the Company,s major,events and pre...undation,s,(CRF) twentieth annual Transcatheter Ca...um, which runs from October 12 to 17 in Washington...de range of safety and,efficacy data on its TAXUS(...
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 1CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 2New Foam Treatment for Varicose Veins 14633 1New Foam Treatment for Varicose Veins 14633 2MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 1MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 1Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 3Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 4Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 5Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 6...4, 2007 - Researchers at,Molecular Insight Pharmac...inical data on MIP-1072, a radiolabeled, small mol...ent for diagnosis and,staging of prostate cancer a...r Medicine (SNM) in Washington, D.C. MIP-1072 is,o...er diagnosis,that Molecular Insight plans to advan...
...ewswire-FirstCall/ --,Bionovo, Inc.,s lead drug ca...r the treatment of hot flashes associated with men...led in the company,s,double-blind, placebo- contro...en with 50 or more moderate to severe hot flashes,... groups receiving,MF101 (5 grams/day), MF101 (10 g...
Other Medicine Technology:Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5